During the past decade, The Chappel Group Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Chappel Group Research" #1 sponsor was "ParaPRO LLC" with 2 trials, followed by "Romark Laboratories L.C." with 2 trials sponsored, "Emergo Therapeutics, Inc." with 1 trials sponsored, "Encube Ethicals Pvt. Ltd." with 1 trials sponsored and "Ferrer Internacional S.A." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Chappel Group Research" #1 collaborator was "Concentrics Research" with 2 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator and "Novum Pharmaceutical Research Services" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "The Chappel Group Research" are "Scabies" (3 trials), "COVID-19" (2 trials), "Influenza" (2 trials), "Viral Respiratory Illnesses" (2 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "The Chappel Group Research" in a lesser frequency.

Most popular intervention types in "The Chappel Group Research" are "Drug" (9 trials), "Dietary Supplement" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Nitazoxanide" (2 trials), "Vitamin Super B-Complex" (2 trials), "spinosad topical suspension, 0.9%" (2 trials) and "Atorvastatin 40 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Chappel Group Research" are 9 trials for "All" genders.

Currently, there are NaN active trials in "The Chappel Group Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in The Chappel Group Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Chappel Group Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".